Zosano Pharma Corp Free cash flow
- Free cash flow · 12 months (USD): Value $-30.92M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2022-03-31..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2022-03-31..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2022-03-31..
- Free cash flow margin · 12 months: Value -4692.26%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2022-03-31..
Free cash flow
Overview →Financial period ending 2022-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-30.92M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2022-03-31. $-28.67M − $2.25M ≈ $-30.92M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2022-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2022-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -4692.26% | (Operating cash flow − capital spending) / revenue. Period ending 2022-03-31. $-30.92M ÷ $659.00K × 100 ≈ -4692.26% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2022-03-31. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-28.67M | Cash generated by operating activities. Period ending 2022-03-31. |
| Operating cash flow / net income · 12 months | 0.52× | Operating cash flow / net income. Period ending 2022-03-31. $-28.67M ÷ $-55.19M ≈ 0.52× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -28.67M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 2.25M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -30.92M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 659.00K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -55.19M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | $-30.92M | (m) | $-28.67M | $2.25M | (m) | $659.00K | (m) | $-55.19M | (m) | (m) | -4692.26% | 0.52× |
| 2021-12-31 | $-33.01M | (m) | $-27.59M | $5.42M | (m) | $785.00K | (m) | $-29.93M | (m) | (m) | -4205.48% | 0.92× |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $-41.07M | (m) | $-30.73M | $10.34M | (m) | $482.00K | (m) | $-32.82M | (m) | (m) | -8521.37% | 0.94× |
| 2020-12-31 | $-40.20M | (m) | $-31.72M | $8.49M | (m) | $224.00K | (m) | $-33.37M | (m) | (m) | -17948.66% | 0.95× |
| 2020-09-30 | $-41.44M | (m) | $-32.90M | $8.53M | (m) | $0.00 | (m) | $-34.21M | (m) | (m) | (m) | 0.96× |
| 2020-06-30 | $-42.90M | (m) | $-32.65M | $10.25M | (m) | (m) | (m) | $-35.39M | (m) | (m) | (m) | 0.92× |
| 2020-03-31 | $-44.92M | (m) | $-35.79M | $9.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-46.58M | (m) | $-34.82M | $11.76M | (m) | $0.00 | (m) | $-37.59M | (m) | (m) | (m) | 0.93× |
| 2019-09-30 | $-46.45M | (m) | $-34.10M | $12.35M | (m) | (m) | (m) | $-38.80M | (m) | (m) | (m) | 0.88× |
| 2019-06-30 | $-42.94M | (m) | $-33.34M | $9.60M | (m) | (m) | (m) | $-37.10M | (m) | (m) | (m) | 0.90× |
| 2019-03-31 | (m) | (m) | (m) | $9.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-34.61M | (m) | $-29.12M | $5.49M | (m) | $0.00 | (m) | $-35.36M | (m) | (m) | (m) | 0.82× |
| 2018-09-30 | (m) | (m) | (m) | $4.62M | (m) | $0.00 | (m) | $-32.70M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $1.62M | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $1.24M | (m) | $0.00 | (m) | $-29.11M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | $671.00K | (m) | $0.00 | (m) | $-29.36M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | $605.00K | (m) | $0.00 | (m) | $-28.94M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | $160.00K | (m) | $0.00 | (m) | $-28.71M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $287.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | $566.00K | (m) | (m) | (m) | $-29.73M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | $644.00K | (m) | (m) | (m) | $-30.90M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | $577.00K | (m) | (m) | (m) | $-31.96M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $432.00K | (m) | $313.00K | (m) | $-28.43M | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | $288.00K | (m) | $693.00K | (m) | $-25.06M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | $554.00K | (m) | $1.07M | (m) | $-20.12M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | $804.00K | (m) | $1.48M | (m) | $-16.45M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | $1.18M | (m) | $2.86M | (m) | $-14.24M | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.